Volume surge · HUM · Healthcare

Humana Inc (HUM) faces heavier weekly selling

A healthcare-plan heavyweight is showing short-term pressure even as its 12-week performance remains positive.

Humana Inc
Latest363.86 USD
1W move-6.5%
Volume1.6x
TrendActive
Humana healthcare-plan materials beside a financial market terminal.

Market update

What happened

Humana Inc (HUM) ended the week at 363.86 USD on July 31, with the weekly price path over 52 weeks showing a -6.5% one-week drop. The decline extends a four-week slide and puts fresh pressure on the recent recovery.

The setup is mixed. Market Dynamics at 0.92 shows confirmation, but Relative Strength is 25.5 and activity expanded, with 11,549,456 shares traded against a 13-week average of 7,426,804.

Continue your research

Explore HUM across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

HUM coverage

Evidence context